Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Botulax vs BOTOX for moderate-to-severe glabellar lines
CTR20170059Phase 3Completed
- Sponsor
- Hugel
- Start
- Feb 2017
- Modality
- Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
A Phase 3 trial of botulinum toxin type A in glabellar furrowing, sponsored by Hugel. Started Feb 2017; status: completed.
02
Drugs
botulinum toxin type A
03
Conditions
glabellar furrowing
Beyond the preview
Go deeper on CTR20170059.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on CTR20170059.